Inspire Corporate Bond ETF (IBD) Stock Overview
Explore Inspire Corporate Bond ETF’s financial performance, market position, analyst ratings, and future outlook.
Inspire Corporate Bond ETF (IBD)
Key Financials
Key Financials
Market Cap
468.5M
P/E Ratio
N/A
EPS (TTM)
N/A
ROE
0.00%
IBD Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of Inspire Corporate Bond ETF (AMEX: IBD) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Inspire Corporate Bond ETF's AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of IBD on the AMEX shows an RSI of 34.83, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $23.68 for the AMEX listing.
Key metrics behind Inspire Corporate Bond ETF's AMEX-traded stock include a P/E ratio of N/A and a market capitalization of 468.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of IBD on the AMEX.